Expression of G1 cyclins, cyclin-dependent kinases, and cyclin-dependent kinase inhibitors in androgen-induced prostate proliferation in castrated rats

Cell Growth and Differentiation

Volumn 7, Issue 11, 1996, Pages 1571-1578

  Chen, Yian ^a   Robles, Ana I ^a   Martinez, Luis A ^a   Liu, Feng ^a   Gimenez Conti, Irma B ^a   Conti, Claudio J ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; CYCLIN DEPENDENT KINASE; CYCLINE; ENZYME INHIBITOR; MESSENGER RNA; TESTOSTERONE;

ANIMAL TISSUE; ARTICLE; CASTRATION; CELL PROLIFERATION; CONTROLLED STUDY; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; MALE; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; PROSTATE; PROSTATE EPITHELIUM; RAT; REGENERATION;

ANIMALS; CELL CYCLE PROTEINS; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLIN-DEPENDENT KINASE INHIBITOR P27; CYCLIN-DEPENDENT KINASES; CYCLINS; ENZYME INHIBITORS; G1 PHASE; GENE EXPRESSION; MALE; MICROTUBULE-ASSOCIATED PROTEINS; ORCHIECTOMY; PHOSPHORYLATION; PROSTATE; RATS; RATS, SPRAGUE-DAWLEY; RETINOBLASTOMA PROTEIN; RNA, MESSENGER; TESTOSTERONE; TUMOR SUPPRESSOR PROTEINS;

ANIMALIA;

EID: 0029960504     PISSN: 10449523     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Nurse, P. Ordering S phase and M phase in the cell cycle. Cell, 79: 547-550, 1994.
2. Hartwell, L. H., and Weinert, T. A. Checkpoints: controls that ensure the order of cell cycle events. Science (Washington DC), 246: 629-634, 1989.
3. Heichman, K. A., and Roberts, J. M. Rules to replicate by. Cell, 79: 557-562, 1994.
4. Sherr, C. J. G1 phase progression: cyclin on cue. Cell, 79: 551-555, 1994.
5. Matsushime, H., Quelle, D. E., Shurtleff, S. A., Shibuya, M., Sherr, C. J., and Kalo, J-Y. D-type cyclin-dependent kinase activity in mammalian cells. Mol. Cell. Biol., 14: 2066-2076, 1994.
6. Koff, A., Giordano, A., Desai, D., Yamashita, K., Harper, W., Elledge, S., Nishimoto, T., Morgan, D., Franza, R., and Roberts, J. Formation and activation of a cyclin E-cdk2 complex during the G1 phase of the human cell-cycle. Science (Washington DC), 257: 1689-1693, 1992.
7. Quelle, D. E., Ashmun, R. A., Shurtleff, S. A., Kato, J-Y., Bar-Sagi, D., Roussel, M. F., and Sherr, C. J. Overexpression of mouse D-type cyclins accelerates G1 phase in rodent fibroblasts. Genes Dev., 7: 1559-1571, 1993.
8. Jiang, W., Kahn, S. M., Zhou, P., Zhang, Y-J., Cacace, A. M., Infante, A. S., Doi, S., Santella, R. M., and Weinstein, I. B. Overexpression of cyclin D1 in rat fibroblasts causes abnormalities in growth control, cell cycle progression and gene expression. Oncogene, 8: 3447-3457, 1993.
9. Resnitzky, D., Gossen, M., Bujard, H., and Reed, S. I. Acceleration of the G1/S phase transition by expression of cyclin D1 and E with an inducible system. Mol. Cell. Biol., 14: 1669-1679, 1994.
10. Ohtsubo, M., and Roberts, J. Cyclin-dependent regulation of G1 in mammalian fibroblasts. Science (Washington DC), 259: 1908-1912, 1993.
11. Sherr, C. J., and Roberts, J. M. Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev., 9: 1149-1163, 1995.
12. Sherr, C. J. Mammalian G1 cyclins. Cell, 73: 1059-1065, 1993.
13. Matsushime, H., Roussel, M. F., Ashmun, R. A., and Sherr, C. J. Colony-stimulating factor 1 regulates novel cyclins during the G1 phase of the cell cycle. Cell, 65: 701-713, 1991.
14. Won, K. A., Xiong, Y., Beach, D., and Gilman, M. Z. Growth-regulated expression of D-type cyclin genes in human diploid fibroblasts. Proc. Natl. Acad. Sci. USA, 89: 9910-9914, 1992.
15. Daksis, J. I., Lu, R. Y., Facchini, L. M., Marhin, W. W., and Penn, L. J. Z. Myc induces cyclin D1 expression in the absence of de novo protein synthesis and links mitogen-stimulated signal transduction to the cell cycle. Oncogene, 9: 3635-3645, 1994.
16. Lu, X. P., Koch, K. S., Lew, D. J., Dulic, V., Pines, J., Reed, S. I., Hunter, T., and Leffert, H. L. Induction of cyclin mRNA and cyclin-associated histone H1 kinase during liver regeneration. J. Biol. Chem., 267: 2841-2844, 1992.
17. Loyer, P., Glaise, D., Cariou, S., Baffet, G., Meijer, L., and Guguen-Guillouzo, C. Expression and activation of Cdks (1 and 2) and cyclins in the cell cycle progression during liver regeneration. J. Biol. Chem., 269: 2491-2500, 1994.
18. Bui, K. C., Buckley, S., Wu, F., Uhal, B., Joshi, I., Liu, J., Hussain, M., Makhoul, I., and Warburton, D. Induction of A- and D-type cyclins and cdc2 kinase activity during recovery from short-term hyperoxic lung injury. Am. J. Physiol., 268: 625-635, 1995.
19. Bruchovsky, N., Lesser, B., Van Dorne, E., and Craven, S. Hormonal effects on cell proliferation in rat prostate. Vitam. Horm., 33: 61-102, 1975.
20. Kyprianou, N., and Isaacs, J. T. Activation of programmed cell death in the rat ventral prostate after castration. Endocrinology, 122: 552-562, 1988.
21. Katz A. E., Benson, M. C., Wise, G. J., Olsson, C. A., Bandyk, M. G., Sawczuk, I. S., Tomashefsky, P., and Buttyan, R. Gene activity during the early phase of androgen-stimulated rat prostate re-growth. Cancer Res., 49: 5889-5894, 1989.
22. Sherwood, E. R., Theyer, G., Steiner, G., Berg, L. A., Kozlowski, J. M., and Lee, C. Differential expression of specific cytokeratin polypeptides in the basal and luminal epithelia of the human prostate. Prostate, 18: 303-314, 1991.
23. Baldin, V., Lukas, J., Marcote, M. J., Pagano, M., and Draetta, G. Cyclin D1 is a nuclear protein required for cell cycle progression in G1. Genes Dev., 7: 812-821, 1993.
24. Xiong, Y., Connolly, T., Futcher, B., and Beach, D. Human D-type cyclin. Cell, 65: 691-699, 1991.
25. Weinberg, R. A. Tumor suppressor genes. Science (Washington DC), 254: 1138-1146, 1991.
26. Horton, L. E., Qian, Y., and Templeton, D. J. G1 cyclins control the retinoblastoma gene product growth regulation activity via upstream mechanisms. Cell Growth & Differ., 6: 395-407, 1995.
27. English, H. F., Drago, J. R., and Santen, R. J. Cellular response to androgen depletion and repletion in the rat ventral prostate: autoradiography and morphometric analysis. Prostate, 7: 41-51, 1985.
28. Furuya, Y., Lin, X. S., Walsh, J. C., Nelson, W. G., and Isaacs, J. T. Androgen ablation-induced programmed death of prostatic glandular cells does not involve recruitment into a defective cell cycle or p53 induction. Endocrinology, 136: 1898-1906, 1995.
29. Gu, W., Schneider, J. W., Condorelli, G., Kaushal, S., Mahdavi, V., and Nadal-Ginard, B. Interaction of myogenic factors and the retinoblastoma protein mediates muscle cell commitment and differentiation. Cell, 72: 309-324, 1993.
30. Toyoshima, H., and Hunter, T. p27, a novel inhibitor of G1 cyclin/cdk protein kinase activity, is related to p21. Cell, 78: 67-74, 1994.
31. Jiang, H., Lin, J., Su, Z-Z., Collart, F. R., Huberman, E., and Fisher, P. B. Induction of differentiation in human promyelocytic HL-60 leukemia cells activates p21, WAF1/CIP, expression in the absence of p53. Oncogene, 9: 3397-3406, 1994.
32. Halevy, O., Novitch, B. G., Spicer, D. B., Skapek, S. X., Rhee, J., Hannon, G. J., Beach, D., and Lasser, A. B. Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by Myo D. Science (Washington DC), 267: 1018-1021, 1995.
33. Sherwood, E. R., Berg, L. A., Mitchell, N. J., McNeal, J. E., Kozlowski, J. M., and Lee, C. Differential cytokeratin expression in normal, hyperplastic and malignant epithelial cells from human prostate. J. Urol., 143: 167-171, 1990.
34. Wang, X., and Hsieh, J. T. Androgen repression of cytokeratin gene expression during rat prostate differentiation: evidence for an epithelial stem cell-associated marker. Chin. Med. Sci. J., 9: 237-241, 1994.
35. Zhang, H., Hannon, G. J., and Beach, D. p21-containing cyclin kinases exist in both active and inactive states. Genes Dev., 8: 1750-1758, 1994.
36. Harper, J. W., Elledge, S. J., Keyomarsi, K., Dynlacht, B., Tsai, L. H., Zhang, P., Dobrowolski, S., Bai, C., Connell-Crowley, L., Swindell, E., Fox, M. P., and Wei, N. Inhibition of cyclin-dependent kinases by p21. Mol. Biol. Cell, 6: 387-400, 1995.
37. Kip1 display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors. Cell, 85: 707-720, 1996.
38. Kyprianou, N., and Isaacs, J. T. Biological significance of measurable androgen levels in the rat ventral prostate following castration. Prostate, 10: 313-324, 1987.
39. Geller, J., Albert, J., Loza, D., Geller, S., Stoeltzing, W., and de la Vega, D. DHT concentrations in human prostate cancer tissue. J. Clin. Endocrinol. Metab., 46: 440-444, 1978.
40. Sheikh, M. S., Li, X-S., Chen, J-C., Shao, Z-M., Ordonez, J. V., and Fontana, J. A. Mechanisms of regulation of WAF1/Cip1 gene expression in human breast carcinoma: role of p53-dependent and independent signal transduction pathway. Oncogene, 9: 3407-3415, 1994.
41. Merlo, G. R., Venesio, T., Bernardi, A., Canale, L., Gaglia, P., Lauro, D., Cappa, A. P., Callahan, R., and Liscia, D. S. Loss of heterozygosity on chromosome 17p13 in breast carcinomas identifies tumors with high proliferation index. Am. J. Pathol., 140: 215-223, 1992.
42. Chomczynski, P., and Sacchi, N. Single step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem., 162: 156-158, 1987.
43. Maniatis, T., Fritsch, E. F., and Sambrook, J. Molecular Cloning: A Laboratory Manual, Ed. 2. pp. 7.46-7.50. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1989.
44. Keyomarsi, K., O'Leary, N., Molnar, G., Lees, E., Fingert, H. J., and Pardee, A. B. Cyclin E, a potential prognostic marker for breast cancer. Cancer Res., 54: 380-385, 1994.